Predicting time to nursing home care and death in individuals with Alzheimer disease

JAMA

Volumn 277, Issue 10, 1997, Pages 806-812

  Stern, Yaakov ^a,b   Tang, Min Xing ^a,b   Albert, Marilyn S ^d   Brandt, Jason ^c   Jacobs, Diane M ^a,b   Bell, Karen ^a,b   Marder, Karen ^a,b   Sano, Mary ^a,b   Devanand, Devangere ^a   Albert, Steven M ^a,b   Bylsma, Frederick ^c   Tsai, Wei Yann ^a  

^a and Epidemiology   (United States)

^b The New York Presbyterian Hospital   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALGORITHM; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CLINICAL FEATURE; COGNITION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NURSING HOME; ONSET AGE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PSYCHOSIS; SEX DIFFERENCE; SURVIVAL RATE;

EID: 8044242205     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.277.10.806     Document Type: Article

References (28)

1. Stern Y, Brandt J, Albert M, et al. Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission and death in Alzheimer's disease. Neurology. 1994;44:2300-2307.
2. Jacobs D, Sano M, Marder K, et al. Age at onset of Alzheimer's disease: relation to pattern of cognitive dysfunction and rate of decline. Neurology. 1994;44:1215-1220.
3. Stern Y, Mayeux R, Sano M, et al. Predictors of disease course in patients with probable Alzheimer's disease. Neurology. 1987;37:1649-1653.
4. Chui HC, Lyness S, Sobel E, et al. Prognostic implications of symptomatic behaviors in Alzheimer's disease. In: Heterogeneity of Alzheimer's Disease. New York, NY: Springer-Verlag; 1992:12-24.
5. Mortimer JA, Ebbitt B, Jun SP, Pinch MD. Predictors of cognitive and functional decline in patients with probable Alzheimer's disease. Neurology. 1992;42:1689-1696.
6. Stern Y, Mayeux R, Sano M, Chen J. Prognostic factors for the progression of probable Alzheimer's disease. Bull Clin Neurosci. 1989;54:73-79.
7. Stern Y, Folstein M, Albert M, et al. Multicenter study of predictors of disease course in Alzheimer disease (the 'Predictors Study'), I. Alzheimer Dis Assoc Disord. 1993;7:3-21.
8. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease. Neurology. 1984;34:939-944.
9. Mayeux R, Stern Y, Sano M, et al. Clinical and biochemical correlates of bradyphrenia in Parkinson's disease. Neurology. 1987;37:1130-1134. Correction: Neurology. 1987;37:1693.
10. Sano M, Stern Y, Mayeux R, et al. A standardized technique for establishing the onset symptoms of probable Alzheimer's disease. J Clin Exp Neuropsychol. 1987;9:65.
11. Stern MB, Hurting HI. The clinical characteristics of Parkinson's disease and Parkinsonian syndromes: diagnosis and assessment. In: The Comprehensive Management of Parkinson's Disease. New York, NY: PMA Corp; 1978:3-50.
12. Richards M, Marder K, Bell K, et al. Interrater reliability of extrapyramidal signs in a group assessed for dementia. Arch Neurol. 1991;48:1147-1149.
13. Devanand DP, Miller L, Richards M, et al. The Columbia University scale for psychopathology in Alzheimer's disease. Arch Neurol. 1992;49:371-376.
14. Mayeux R, Stern Y, Rosen J, Leventhal J. Depression, intellectual impairment and Parkinson's disease. Neurology. 1981;31:645-650.
15. Stern Y, Sano M, Paulson J, Mayeux R. Modified Mini-Mental State Examination: validity and reliability. Neurology. 1987;37(suppl 1):179.
16. Folstein MF, Folstein SE, McHugh PR. 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
17. Wechsler D. Wechsler Adult Intelligence Scale-Revised. New York, NY: Psychological Corp; 1981.
18. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of senile change in the cerebral grey matter of elderly subjects. Br J Psychol. 1968;114:797-811.
19. Hughes CP, Berg L, Danziger WL, et al. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;146:566-572.
20. Stern Y, Albert SM, Sano M, et al. Assessing patient dependence in Alzheimer's disease. J Gerontol. 1994;49:M216-M222.
21. Katzman R, Brown T, Fuld P, et al. Validation of a short orientation-memory-concentration test of cognitive impairment. Am J Psychiatry. 1983; 140:734-739.
22. Buschke H, Fuld PA. Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology. 1974;24:1019-1025.
23. Hixson J, Vernier D. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhAI. J Lipid Res. 1991;31:545-548.
24. Collet D. Modelling Survival Data in Medical Research. London, England: Chapman and Hall; 1994:153.
25. Tysnes OB, Vollset SE, Larsen JP, Aarli JA. Prognostic factors and survival in amyotrophic lateral sclerosis. Neuroepidemiology. 1994;13:226-235.
26. Corder EH, Saunders AM, Strittmatter WJ, et al. Apolipoprotein E, survival in Alzheimer's disease patients, and competing risks of death and Alzheimer's disease. Neurology. 1995;45:1323-1328.
27. Frisoni GB, Govoni S, Geroldi C, et al. Gene dose of the ∈4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Ann Neurol. 1995;37:596-604.
28. van Dujin CM, de Knijff P, Wehnert A, et al. The apolipoprotein E ∈2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Ann Neurol. 1995;37:605-610.